CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown.
This page is built on request from the registry's record of the paper. The 6,000 most recent papers have a fuller page, built ahead of time, with the Code ↔ Paper reader, the tracing map and its validation, the record's versions, how to cite it and similar papers. This paper is older: its record, its code, its data and the requests about it are below.
Overview
Code
The paper links to its data and to no code of its authors: see the Data section.
Data
Datasets cited
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI
Contribute
The authors of this paper can claim it and correct its record, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to the registry's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors or correct its record: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record.
Request its removal
To ask for this record, the copies of its authors' scripts or its tracing map to be removed, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).